Accession Number: | 0001179110-19-010889 |
Date: | 2019-10-07 |
Issuer: | KINIKSA PHARMACEUTICALS, LTD. (KNSA) |
Original Submission Date: |
PAOLINI JOHN F.
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON, D0 HM11
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
CLASS A COMMON SHARES | 2019-10-07 | M | 10,000 | a | $1.86 | 10,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SHARE OPTION | 1.86 | 2019-10-07 | deemed execution date | M | 10,000 (d) | 2026-09-13 | class a common shares 10,000 | $1.86 | 217,574 | direct |
ID | footnote |
---|---|
f1 | the option vested and became exercisable as to 25% of the total grant of 227,574 class a common shares on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three-year period thereafter. the vesting commencement date is august 15, 2016. |